-
平臺(tái)編號(hào)：bio-129584
-
細(xì)胞信息： HMy2.C1R
-
規(guī)格：1×10?cells/T25培養(yǎng)瓶
-
用途：細(xì)胞系
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
人B淋巴母細(xì)胞HMy2.C1R
細(xì)胞名稱：人B淋巴母細(xì)胞HMy2.C1R
產(chǎn)品規(guī)格：T25培養(yǎng)瓶x1；1.5ml凍存管x2
細(xì)胞數(shù)量：1x10^6；1x10^6
保存溫度：37℃；-198℃
運(yùn)輸方式：常溫保溫運(yùn)輸；干冰運(yùn)輸
安全等級(jí)：1
用途限制：僅供科研3類
培養(yǎng)體系：DMEM高糖（不含丙酮酸鈉）+10%FBS+1%三抗
培養(yǎng)溫度：37℃
二氧化碳濃度：5%
簡(jiǎn)介：人B淋巴母細(xì)胞HMy2.C1R取自33歲女性供體。
注釋：Part of:12th International Histocompatibility Workshop(12IHW)cell line panel.
Transformant:NCBI_TaxID;10376;Epstein-Barr virus(EBV).
Transformant:NCIt;C44386;Gamma radiation.
Derived from sampling site:Peripheral blood.
突變信息：/
STR信息
Amelogenin X
CSF1PO 6,10
D5S818 10,13
D7S820 7,12
D13S317 11,13
D16S539 9,13
TH01 8
TPOX 8
vWA 17
參考文獻(xiàn)
PubMed=3819393
Storkus W.J.,Howell D.N.,Salter R.D.,Dawson J.R.,Cresswell P.
NK susceptibility varies inversely with target cell class I HLA antigen expression.
J.Immunol.138:1657-1659(1987)
PubMed=2784569;DOI=10.1073/pnas.86.7.2361
Storkus W.J.,Alexander J.,Payne J.A.,Dawson J.R.,Cresswell P.
Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.
Proc.Natl.Acad.Sci.U.S.A.86:2361-2364(1989)
PubMed=1541831
Zemmour J.,Little A.-M.,Schendel D.J.,Parham P.
The HLA-A,B'negative'mutant cell line C1R expresses a novel HLA-B35 allele,which also has a point mutation in the translation initiation codon.
J.Immunol.148:1941-1948(1992)
細(xì)胞操作說(shuō)明書(shū)下載：細(xì)胞操作說(shuō)明書(shū)
產(chǎn)品規(guī)格：T25培養(yǎng)瓶x1；1.5ml凍存管x2
細(xì)胞數(shù)量：1x10^6；1x10^6
保存溫度：37℃；-198℃
運(yùn)輸方式：常溫保溫運(yùn)輸；干冰運(yùn)輸
安全等級(jí)：1
用途限制：僅供科研3類
培養(yǎng)體系：DMEM高糖（不含丙酮酸鈉）+10%FBS+1%三抗
培養(yǎng)溫度：37℃
二氧化碳濃度：5%
簡(jiǎn)介：人B淋巴母細(xì)胞HMy2.C1R取自33歲女性供體。
注釋：Part of:12th International Histocompatibility Workshop(12IHW)cell line panel.
Transformant:NCBI_TaxID;10376;Epstein-Barr virus(EBV).
Transformant:NCIt;C44386;Gamma radiation.
Derived from sampling site:Peripheral blood.
突變信息：/
STR信息
Amelogenin X
CSF1PO 6,10
D5S818 10,13
D7S820 7,12
D13S317 11,13
D16S539 9,13
TH01 8
TPOX 8
vWA 17
參考文獻(xiàn)
PubMed=3819393
Storkus W.J.,Howell D.N.,Salter R.D.,Dawson J.R.,Cresswell P.
NK susceptibility varies inversely with target cell class I HLA antigen expression.
J.Immunol.138:1657-1659(1987)
PubMed=2784569;DOI=10.1073/pnas.86.7.2361
Storkus W.J.,Alexander J.,Payne J.A.,Dawson J.R.,Cresswell P.
Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.
Proc.Natl.Acad.Sci.U.S.A.86:2361-2364(1989)
PubMed=1541831
Zemmour J.,Little A.-M.,Schendel D.J.,Parham P.
The HLA-A,B'negative'mutant cell line C1R expresses a novel HLA-B35 allele,which also has a point mutation in the translation initiation codon.
J.Immunol.148:1941-1948(1992)
細(xì)胞操作說(shuō)明書(shū)下載：細(xì)胞操作說(shuō)明書(shū)
